Concepedia

Jana Tomisch

JT

Statistics

Publications

3

Citations

67

H-Index

3

Active since

2022

Affiliations

University of Freiburg(Current)

Kazan Institute of Biochemistry and Biophysics

Jana Tomisch is an author at University of Freiburg specializing in oncology, tumor-associated antigens, and tumor antigens.

ORCID

Publications per year

2022–2023

3

Publications

3

Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells

Ana Valeria Meléndez, Rubí M.-H. Velasco Cárdenas, Simon Lagies et al. · Cellular and Molecular Life Sciences · 2022 · 33 citations · Full text

, , +17

A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death

Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch et al. · Journal of Translational Medicine · 2022 · 24 citations · Full text

, , +17

A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer Cells

Jana Tomisch, Vincent Busse, Francesca Rosato et al. · Cells · 2023 · 10 citations · Full text

, , +17

1–3 of 3